These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3625206)

  • 1. The rapid assessment of visual dysfunction in multiple sclerosis.
    Della Sala S; Comi G; Martinelli V; Somazzi L; Wilkins AJ
    J Neurol Neurosurg Psychiatry; 1987 Jul; 50(7):840-6. PubMed ID: 3625206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.
    Longbrake EE; Lancia S; Tutlam N; Trinkaus K; Naismith RT
    Mult Scler Relat Disord; 2016 Nov; 10():198-203. PubMed ID: 27919490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 20/20 eye in multiple sclerosis.
    Kupersmith MJ; Nelson JI; Seiple WH; Carr RE; Weiss PA
    Neurology; 1983 Aug; 33(8):1015-20. PubMed ID: 6683795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual function in multiple sclerosis.
    Ashworth B; Aspinall PA; Mitchell JD
    Doc Ophthalmol; 1989 Nov; 73(3):209-24. PubMed ID: 2638240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
    Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The flight of colours test. Its value as an indicator of dysfunction of the visual pathways.
    Hamilton-Bruce MA; Black AB
    Clin Exp Neurol; 1988; 25():97-102. PubMed ID: 3267491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests.
    van Diemen HA; Lanting P; Koetsier JC; Strijers RL; van Walbeek HK; Polman CH
    Clin Neurol Neurosurg; 1992; 94(3):191-5. PubMed ID: 1327607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test.
    Regan D; Silver R; Murray TJ
    Brain; 1977 Sep; 100(3):563-79. PubMed ID: 589432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do visual evoked potentials give relevant information to the neuro-ophthalmological examination in optic nerve lesions?
    Nikoskelainen E; Falck B
    Acta Neurol Scand; 1982 Jul; 66(1):42-57. PubMed ID: 7113679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
    Grecescu M
    J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
    Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
    J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of contrast reduction on pattern-reversal VEPs in suspected multiple sclerosis and optic neuritis.
    Davidson AW; Scott RF; Mitchell KW
    Doc Ophthalmol; 2004 Sep; 109(2):157-61. PubMed ID: 15881261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual loss in multiple sclerosis and its relation to previous optic neuritis, disease duration and clinical classification.
    Honan WP; Heron JR; Foster DH; Edgar GK; Scase MO; Collins MF
    Brain; 1990 Aug; 113 ( Pt 4)():975-87. PubMed ID: 2397395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of hidden visual loss in optic neuropathy: VISTECH test at variable illuminations.
    Leys MJ; Candaele CM; Uvijls AG; Heintz BF; De Rouck AF; Odom JV
    Bull Soc Belge Ophtalmol; 1990; 236():57-65. PubMed ID: 2093407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spatial contrast sensitivity in multiple sclerosis].
    Vighetto A; Grochowicki M; Cousin J
    Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of static perimetry in subclinical optic neuritis in multiple sclerosis].
    Mauguière F; Perret-Magloire E
    Rev Neurol (Paris); 1983; 139(12):745-52. PubMed ID: 6665389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of hidden visual loss in multiple sclerosis. A comparison of pattern-reversal visual evoked potentials and contrast sensitivity.
    Leys MJ; Candaele CM; De Rouck AF; Odom JV
    Doc Ophthalmol; 1991; 77(3):255-64. PubMed ID: 1760973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VISTECH contrast sensitivity and pattern-VEP in multiple sclerosis patients.
    Augustinus B; Van den Bergh L; Zeyen T
    Bull Soc Belge Ophtalmol; 1990; 236():89-96. PubMed ID: 2093410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decrease in spatial contrast sensitivity and Pulfrich's stereoillusion in multiple sclerosis patients].
    Zanen A
    Bull Soc Belge Ophtalmol; 1982; 199-200():95-115. PubMed ID: 6763548
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of tests evaluating visual functions in detecting overt or subclinical optic neuritis in multiple sclerosis.
    Öcek Ö; Gedizlioğlu M; Köşkderelioğlu A; Ortan PK; Yüksel B; Türe M; Gediz F
    Mult Scler Relat Disord; 2018 Apr; 21():63-68. PubMed ID: 29471193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.